Facebook
X
LinkedIn
Forward
COVID-19 Vaccine Information
- Latest information on COVID vaccines from the CDC
- COVID Vaccine Safety
- WHO epidemiological reports on COVID-19 information
- COVID Vaccine Allergic Reactions/Adverse Events
- Annals Articles
Allergic reactions to the COVID-19 Vaccine (ARCOV) Study: The McGill\University Health Center (MUHC) Experience (May 21, 2022)
What Have We Learned About the Allergenicity and Adverse Reactions Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines (April 4, 2022)
- Annals Articles
Allergy & Immunology Clinician Resources
- Managing Your Asthma Patients During COVID (5/28/2020)
- GINA Inhaled Asthma Controller Recommendations
- DocMatter (Member Discussion Platform)
Billing & Coding
Reimbursement for telemedicine, waived restrictions
- Coding for Telehealth (5/2022)
Overview of COVID-19
From the Journals
- The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review (Annals of Allergy, Asthma & Immunology, January 2023)
- Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination (Annals of Allergy, Asthma & Immunology, January 2023)
- A study in the European Respiratory Journal found an association between individuals with markers of autoimmune disease and long-COVID symptoms (Sept. 2022)
- What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later (Annals of Allergy, Asthma & Immunology, April 2022)
- STRATIFYING RISK FOR LONG COVID IN PATIENTS WITH IMMUNODEFICIENCY [Nov. 2024]
Telemedicine